Reporte zur Charge U005104

Symptomtext

No additional AE details provided. No additional AE reported; MMR II was administered intramuscularly instead of subcutaneously; This spontaneous report was received form a medical assistant referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, concomitant medications, and drug reactions or allergies was not provided. On 02-SEP-2022, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) intramuscularly instead of subcutaneously, with lot# T031436 with expiration date 15-SEP-2022 (albumin status rHA) for prophylaxis (dose and frequency not reported), together with sterile diluent lot # U005104 with expiration date 01-JUL-2023. No additional adverse event (AE) details provided or reported.